<?xml version="1.0" encoding="UTF-8"?>
<p>Postoperative adjuvant chemotherapy with S-1 was administered to 27 of the 29 patients who underwent R0 resection. Two patients with R0 resection and 1 with R1 refused additional treatment (
 <xref rid="f1" ref-type="fig">Figure 1</xref>). Of the 27 patients who received postoperative adjuvant chemotherapy, 13 (48.1%) completed postoperative chemotherapy with S-1 for 1Â year, whereas 8 discontinued treatment due to toxicity, and 6 discontinued it due to recurrence.
</p>
